Summary
The renal effects of bumetanide, a new diuretic chemically related to furosemide, have been studied in four young healthy volunteers during dehydration and water diuresis. Bumetanide produced a considerable diuresis due mainly to an increase in osmotic clearance. The peak urinary volume amounted to about 1/3 of the filtered volume, indicating an effect of the drug on the proximal tubule. Free water clearance was not significantly affected. During dehydration, with its superimposed osmotic diuresis, bumetanide diminished the concentrating power of the kidney so that an almost isotonic urine was produced. This result implied an additional effect on the distal parts of the nephron and it may represent partial blockade of sodium reabsorption in the ascending limb of the loop of Henle.
Similar content being viewed by others
References
Asbury, M.J., Gatenby, P.B.B., O'Sullivan, S., Bourke, E.: Bumetanide: Potent new “loop” diuretic. Brit. med. J.1972 I, 211
Bojs, G.: An experimental study on serotonin on man with special reference to renal function. Scand. J. clin. Lab. Invest. Suppl.55, 10 (1961)
Buchborn, E., Anastasakis, S.: Angriffspunkt und Wirkungsmechanismus von Furosemid am distalen Nephron des Menschen. Klin. Wschr.42, 1127 (1964)
Feit, P.: Aminobenzoic acid diuretics. 2. 4-Substituted-3-amino-5-sulfanylbenzoic acid derivates. J. med. pharm. Chem.14, 432 (1971)
Henning, R., Lundvall, O.: Evaluation in man of bumetanide, a new diuretic agent. Europ. J. clin. Pharmacol.6, 224 (1973)
Morrin, P.A.F.: The effect of furosemide, a new diuretic agent, on renal concentrating and diluting mechanisms. Canad. J. Physiol. Pharmacol.44, 129 (1966)
Ostergaard, E.H., Magnussen, M.P., Kaergaard Nielsen, Chr., Eilertsen, E., Frey, H.-H.: Pharmacological properties of bumetanide, a new potent diuretic. Arzneimittel-Forsch.22, 66 (1972)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Karlander, S.G., Henning, R. & Lundvall, O. Renal effects of bumetanide, a new saluretic agent. Eur J Clin Pharmacol 6, 220–223 (1973). https://doi.org/10.1007/BF00644735
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00644735